Prospective Zantac plaintiffs will include anyone who used Zantac on a regular basis for any extended period of time and was subsequently diagnosed with cancer. The strongest plaintiffs will be those diagnosed with specific types of cancer that are closely linked to NDMA and the gastrointestinal system which Zantac impacts. These include:

• Liver cancer
• Stomach Cancer
• Bladder Cancer
• Intestinal Cancer
• Colorectal Cancer
• Esophageal Cancer